The Thymidine Kinase-2 Deficiency Treatment market was valued at 1.31 USD in 2024 and is expected to reach 3.74 USD by 2032, growing at a CAGR of 6.1% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.